Intarcia Therapeutics, Inc. Bets It Will Shake Up Diabetes Treatment With Implantable Device

Xconomy -- Diabetes is supposed to be one of the biggest public health threats facing the U.S. over the next decade, yet if you talk to anybody developing drugs for this chronic disease, times have never been tougher. So how can Kurt Graves, the executive chairman at Hayward, CA-based Intarcia Therapeutics, sound so relentlessly upbeat?

Back to news